Gilead Sciences stock slips 0.19 percent ahead of the open
Published on 09/22/2026 at 07:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Gilead Sciences stock closed at USD 150.56 on the Nasdaq on September 21, 2026, down 0.19 percent. The Nasdaq Composite rose 2.26 percent to 27,122.09 in the same session, leaving Gilead behind the reference index.
September 21, 2026 in numbers
Gilead Sciences, Inc. (ISIN US3755581036) finished at USD 150.56 on the Nasdaq on September 21, 2026. Simply Wall St reported on September 22, 2026, that the latest close stood at USD 150.56 and described the companys HIV prevention access agreements involving royalty free lenacapavir licenses in 120 high incidence countries and an agreement with the Pan American Health Organization.
The Nasdaq Composite closed at 27,122.09 on September 21, 2026, up 2.26 percent, according to The Straits Times. Gilead also had a last reported close of USD 150.56, while a separate valuation narrative cited fair value of USD 128.38.
Dividend date on September 29, 2026
A dividend is scheduled to be payable on September 29, 2026, according to Ad hoc news. The same report identifies October 29, 2026 as the estimated date for the next quarterly earnings release.
